MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation

被引:395
作者
Dorsett, Yair [1 ]
McBride, Kevin M. [1 ]
Jankovic, Mila [1 ]
Gazumyan, Anna [1 ,2 ]
Thai, To-Ha [3 ]
Robbiani, Davide F. [1 ]
Di Virgilio, Michela [1 ]
San-Martin, Bernardo Reina [4 ]
Heidkamp, Gordon [1 ]
Schwickert, Tanja A. [1 ]
Eisenreich, Thomas [1 ]
Rajewsky, Klaus [3 ]
Nussenzweig, Michel C. [1 ,2 ]
机构
[1] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA
[2] Howard Hughes Med Inst, New York, NY 10065 USA
[3] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA
[4] ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France
关键词
D O I
10.1016/j.immuni.2008.04.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MicroRNAs (miRNAs) are small noncoding RNAs that regulate vast networks of genes that share miRNA target sequences. To examine the physiologic effects of an individual miRNA-mRNA interaction in vivo, we generated mice that carry a mutation in the putative microRNA-155 (miR-155) binding site in the T-untranslated region of activation-induced cytidine deaminase (AID), designated Aicda(155) mice. AID Is required for immunoglobulin gene diversification in B lymphocytes, but it also promotes chromosomal translocations. Aicda(155) caused an increase in steady-state Aicda mRNA and protein amounts by increasing the half-life of the mRNA, resulting in a high degree of Myc-Igh translocations. A similar but more pronounced translocation phenotype was also found in miR-155-deficient mice. Our experiments indicate that miR-155 can act as a tumor suppressor by reducing potentially oncogenic translocations generated by AID.
引用
收藏
页码:630 / 638
页数:9
相关论文
共 72 条
  • [1] THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE
    ADAMS, JM
    HARRIS, AW
    PINKERT, CA
    CORCORAN, LM
    ALEXANDER, WS
    CORY, S
    PALMITER, RD
    BRINSTER, RL
    [J]. NATURE, 1985, 318 (6046) : 533 - 538
  • [2] AID from bony fish catalyzes class switch recombination
    Barreto, VM
    Pan-Hammarstrom, Q
    Zhao, YF
    Hammarstrom, L
    Misulovin, Z
    Nussenzweig, MC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) : 733 - 738
  • [3] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [4] The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation
    Basu, U
    Chaudhuri, J
    Alpert, C
    Dutt, S
    Ranganath, S
    Li, G
    Schrum, JP
    Manis, JP
    Alt, FW
    [J]. NATURE, 2005, 438 (7067) : 508 - 511
  • [5] Role of activation-induced deaminase protein kinase a phosphorylation sites in Ig gene conversion and somatic hypermutation
    Chatterji, Monalisa
    Unniraman, Shyam
    McBride, Kevin M.
    Schatz, David G.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 179 (08) : 5274 - 5280
  • [6] Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430
    Choi, Wen-Yee
    Giraldez, Antonio J.
    Schier, Alexander F.
    [J]. SCIENCE, 2007, 318 (5848) : 271 - 274
  • [7] Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases
    Conticello, SG
    Thomas, CJF
    Petersen-Mahrt, SK
    Neuberger, MS
    [J]. MOLECULAR BIOLOGY AND EVOLUTION, 2005, 22 (02) : 367 - 377
  • [8] Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4
  • [9] Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
    Costinean, S
    Zanesi, N
    Pekarsky, Y
    Tili, E
    Volinia, S
    Heerema, N
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (18) : 7024 - 7029
  • [10] Molecular mechanisms of antibody somatic hypermutation
    Di Nola, Javier M.
    Neuberger, Michael S.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2007, 76 : 1 - 22